Market closed

Novanta/$NOVT

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Novanta

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Ticker

$NOVT

Sector

Information Technology

Trading on

NASDAQ

Industry

Electronic Equipment, Instruments & Components

Headquarters

Bedford, United States

Employees

2,900

Website

www.novanta.com

Novanta Metrics

BasicAdvanced

$5.3B

88.05 $1.66

1.29 -

Price and volume

Market cap

$5.3B

Beta

1.29

52-week high

$187.12

52-week low

$143.18

Average daily volume

187K

Financial strength

Current ratio

2.79

Quick ratio

1.642

Long term debt to equity

66.718

Total debt to equity

67.393

Interest coverage (TTM)

3.66%

Management effectiveness

Return on assets (TTM)

5.35%

Return on equity (TTM)

8.67%

Valuation

Price to earnings (TTM)

88.046

Price to revenue (TTM)

5.69

Price to book

7.07

Price to tangible book (TTM)

-104.4

Price to free cash flow (TTM)

45.735

Growth

Revenue change (TTM)

3.86%

Earnings per share change (TTM)

-20.95%

3-year revenue growth (CAGR)

12.08%

3-year earnings per share growth (CAGR)

6.36%

What the Analysts think about Novanta

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Novanta stock.

Novanta Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Novanta Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Novanta News

AllArticlesVideos

Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025

Business Wire·4 weeks ago

Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025

Business Wire·4 weeks ago

Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NOVT

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Novanta stock?

Novanta (NOVT) has a market cap of $5.3B as of January 15, 2025.

What is the P/E ratio for Novanta stock?

The price to earnings (P/E) ratio for Novanta (NOVT) stock is 88.05 as of January 15, 2025.

Does Novanta stock pay dividends?

No, Novanta (NOVT) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Novanta dividend payment date?

Novanta (NOVT) stock does not pay dividends to its shareholders.

What is the beta indicator for Novanta?

Novanta (NOVT) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.